12:00 AM
Nov 02, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Intermezzo zolpidem regulatory update

FDA issued a complete response letter to Transcept for Intermezzo zolpidem to treat insomnia when a middle of the night awakening is followed by difficulty returning to sleep. In the letter,...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >